Related Experiment Video
Updated: Jun 29, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or
Sebastian Freilinger1, Harald Kaemmerer1, Robert D Pittrow2
1International Center for Adults With Congenital Heart Disease, Clinic for Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University Munich, München, Germany.
The PATHFINDER-CHD registry will collect data on heart failure in adults with congenital heart defects (ACHD). This aims to improve understanding and management of heart failure (HF) in this underserved population.
Area of Science:
- Cardiology
- Public Health
Background:
- Adults with congenital heart defects (ACHD) represent an underserved population with significant lifelong physical and psychosocial challenges.
- Heart failure (HF) is a major cause of morbidity and mortality in ACHD patients, necessitating specialized care.
Purpose of the Study:
- To establish the prospective PATHFINDER-CHD registry for comprehensive data collection on HF in ACHD.
- To improve understanding and management of HF in ACHD, informing treatment strategies and interventions.
Main Methods:
- A multicenter observational study across German university facilities specializing in ACHD.
- Prospective data collection on real-world treatment, clinical trajectories, and outcomes in ACHD patients with or at risk for HF.
Main Results:
- The registry will capture diverse patient data, including those undergoing various cardiac therapies, surgery, or transplantation.
- Longitudinal data acquisition will track disease progression and treatment impacts in real-time.
Conclusions:
- The PATHFINDER-CHD Registry will provide crucial insights into HF management for ACHD patients.
- This initiative aims to bridge knowledge gaps, enhance patient care, and guide future research in this field.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

